Ton N.M. Schumacher
Cited by
Cited by
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ...
Science 348 (6230), 124-128, 2015
Neoantigens in cancer immunotherapy
TN Schumacher, RD Schreiber
Science 348 (6230), 69-74, 2015
Mutations associated with acquired resistance to PD-1 blockade in melanoma
JM Zaretsky, A Garcia-Diaz, DS Shin, H Escuin-Ordinas, W Hugo, ...
New England Journal of Medicine 375 (9), 819-829, 2016
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ...
Nature 515 (7528), 577-581, 2014
Synergism of cytotoxic T lymphocyte–associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of …
RPM Sutmuller, LM Van Duivenvoorde, A Van Elsas, TNM Schumacher, ...
Journal of Experimental Medicine 194 (6), 823-832, 2001
Empty MHC class I molecules come out in the cold
HG Ljunggren, NJ Stam, C Öhlén, JJ Neefjes, P Höglund, MT Heemels, ...
Nature 346 (6283), 476-480, 1990
Science forum: the human cell atlas
A Regev, SA Teichmann, ES Lander, I Amit, C Benoist, E Birney, ...
elife 6, e27041, 2017
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
CD27 is required for generation and long-term maintenance of T cell immunity
J Hendriks, LA Gravestein, K Tesselaar, RAW van Lier, TNM Schumacher, ...
Nature immunology 1 (5), 433-440, 2000
Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma
N van Rooij, MM van Buuren, D Philips, A Velds, M Toebes, B Heemskerk, ...
Journal of clinical oncology: official journal of the American Society of …, 2013
Regulation and function of the PD-L1 checkpoint
C Sun, R Mezzadra, TN Schumacher
Immunity 48 (3), 434-452, 2018
Generation of peptide–MHC class I complexes through UV-mediated ligand exchange
B Rodenko, M Toebes, SR Hadrup, WJE Van Esch, AM Molenaar, ...
Nature protocols 1 (3), 1120-1132, 2006
B cells and tertiary lymphoid structures promote immunotherapy response
BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ...
Nature 577 (7791), 549-555, 2020
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
C Linnemann, MM Van Buuren, L Bies, EME Verdegaal, R Schotte, ...
Nature medicine 21 (1), 81-85, 2015
The “cancer immunogram”
CU Blank, JB Haanen, A Ribas, TN Schumacher
Science 352 (6286), 658-660, 2016
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
L Diehl, AT den Boer, SP Schoenberger, EIH van der Voort, ...
Nature medicine 5 (7), 774-779, 1999
Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers
RS Andersen, P Kvistborg, TM Frøsig, NW Pedersen, R Lyngaa, ...
Nature protocols 7 (5), 891-902, 2012
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro
TNM Schumacher, MT Heemels, JJ Neefjes, WM Kast, CJM Melief, ...
Cell 62 (3), 563-567, 1990
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective
JC Shepherd, TNM Schumacher, PG Ashton-Rickardt, S Imaeda, ...
Cell 74 (3), 577-584, 1993
The system can't perform the operation now. Try again later.
Articles 1–20